Ingavirin

Antiviral drug

Ingavirin
INN
Drug class
Routes of administration
Pregnancy category
Bioavailability
Metabolism
Elimination half-life
Excretion
Legal status
CAS Number
PubChem
DrugBank
ChemSpider
KEGG

Ingavirin is an antiviral drug that is used primarily in the treatment of influenza and other respiratory viral infections. It is known for its ability to inhibit the replication of viruses and modulate the immune response.

Mechanism of Action

Ingavirin works by interfering with the replication of viral particles within the host cells. It is believed to inhibit the nuclear import of viral ribonucleoproteins, thereby preventing the assembly of new viral particles. Additionally, Ingavirin modulates the production of interferons and other cytokines, enhancing the body's immune response to viral infections.

Pharmacokinetics

Ingavirin is administered orally and is rapidly absorbed into the bloodstream. It is distributed throughout the body and reaches peak plasma concentrations within a few hours. The drug is primarily excreted through the kidneys, with a half-life of approximately 24 hours, allowing for once-daily dosing.

Clinical Use

Ingavirin is indicated for the treatment of influenza A and B, as well as other acute respiratory viral infections. It is most effective when administered within the first 48 hours of symptom onset. The drug is available in capsule form and is typically prescribed for a course of 5 to 7 days.

Side Effects

Common side effects of Ingavirin include mild gastrointestinal disturbances, such as nausea and diarrhea. Some patients may experience allergic reactions, including rash and itching. Serious side effects are rare but can include liver dysfunction and hematological abnormalities.

Contraindications

Ingavirin is contraindicated in individuals with known hypersensitivity to the drug or its components. It is also not recommended for use in pregnant or breastfeeding women due to a lack of sufficient safety data.

Research and Development

Ingavirin was developed in Russia and has been the subject of various clinical trials to assess its efficacy and safety. Ongoing research is focused on expanding its use to other viral infections and understanding its full mechanism of action.

Related Pages

• Antiviral drug
• Influenza
• Interferon